You are here
TENDEL THERAPIES INC.
UEI: JA9BDUH73852
# of Employees: 5
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
CCR5 immunotoxins as components of HIV cure regimens
Amount: $300,000.00This project will establish proof-of-concept for CCR5 immunotoxins as HIV reservoir-depletion agents for use in cure strategies. HIV cure and remission strategies require elimination or reduction of t ...
STTRPhase I2022Department of Health and Human Services National Institutes of Health -
Memory-promoting Ad vaccine for long-lived protection against SARS-CoV-2
Amount: $299,983.00This grant will establish immunologic proof-of-concept for a second-generation SARS-CoV-2 vaccine providing extraordinarily durable T-cell and antibody responses, which together protect the respirator ...
STTRPhase I2021Department of Health and Human Services National Institutes of Health -
Nucleic acid-based formulation of cytomegalovirus-vectored HIV vaccines
Amount: $300,000.00This grant is for translational development of a scalable, nucleic acid-based formulation of cytomegalovirus-vectored vaccines that can be distributed without a cold chain. HIV candidate vaccines that ...
STTRPhase I2020Department of Health and Human Services National Institutes of Health